Author:
Waked I.,Amin M.,Abd El Fattah S.,Osman L.M.,Sabbour M.S.
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference55 articles.
1. Schalm SW, Summerskill WHJ, Gitnick GL, Elveback LR. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis B s antigen. Gut, 1976; 17: 781–786.
2. Lam KC, Lai CL, Ng RP, Trepo C, Wu PC. Deleterious effect of prednisolone in HBsAg positive chronic active hepatitis. N Engl J Med, 1981; 304: 380–386.
3. Wu PC, Lai CL, Lam KC, Ho J. Prednisolone in HBsAg-positive chronic active hepatitis: Histologic evaluation in a controlled prospective study. Hepatology, 1982; 2: 777–783.
4. Bahgat MH, Sabbour MS, Osman LM, Ghali AF, Gadallah MA. Comparative Study of different types of treatment in chronic active hepatitis. Chemioterapia 1985; 4, 227–235.
5. Tanno H, Fay OH, Rojman JA, Palazzi J, Bessone F. HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis. In: Zuckerman AJ, (ed): Viral Hepatitis and Liver Disease. New York, Alan R Liss, Inc., 1988: 940–943.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献